YARW

NASD Yarrow Bioscience, Inc.
Oct 21, 2026 · 4:12 AM ET EOD Market Closed

$20.21 ↑ +0.00 (+0.00%) Trading Up from the previous close of $20.21, $0.28 below the day’s high of $20.49

YTD change
-27.95%
vs 20-day SMA
-7.66%
vs 200-day SMA
N/A

Price ranges

Previous day
$19.33 $20.49
open $19.87 close $20.21
+$0.34 (+1.71%)
Today
$19.33 $20.49
$20.21
Past week
$18.05 $20.39
from $19.82 now $20.21
+$0.39 (+1.97%)
Past month
$18.05 $29.00
from $28.30 now $20.21
-$8.09 (-28.59%)
This year
$18.05 $44.28
from $28.05 now $20.21
-$7.84 (-27.95%)

Price & Performance

-7.84 (-27.95%) / 6M

$16.34$25.86$35.39$44.91Jul 28Sep 8Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 57.0% away from all-time highs of $46.95
  • YARW is down 28% since the beginning of the year
  • YARW is down 28% over the past 12 months
  • YARW is down 29% over the past 1 month
  • 3% of all YARW investors are betting against YARW

YARW reads neutral: the 12-month move is -28.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-2.14
Earnings momentum +86.6% Quarterly EPS growth
Quarterly change +86.6%

Valuation

P/E ratio N/A
Enterprise value $-5782160.0
Beta 1.22

Balance sheet & scale

IncomeN/A
Revenue$482.0K
Cash$22.9M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $190.8M

Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.94 +3.29%
MRNA Moderna, Inc. $242.08 +6.69%
RVMD Revolution Medicines, Inc. $196.55 +7.91%
ROIV Roivant Sciences Ltd. $34.92 +0.63%
BNTX BioNTech SE Sponsored ADR $91.17 +2.20%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.